Personal Capital Advisors’s Biogen BIIB Stock Holding History

Personal Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-739	Closed	-$209K	–	551
2021 Q3	$209K	Buy	739 +13	+2%	+$4.26K	﹤0.01%	477
2021 Q2	$251K	Sell	726 -16	-2%	-$4.85K	﹤0.01%	430
2021 Q1	$208K	Buy	+742	New	+$200K	﹤0.01%	456
2020 Q4	–	Sell	-830	Closed	-$235K	–	459
2020 Q3	$235K	Buy	830 +40	+5%	+$11.2K	﹤0.01%	374
2020 Q2	$211K	Sell	790 -18	-2%	-$5.41K	﹤0.01%	341
2020 Q1	$255K	Sell	808 -123	-13%	-$37.3K	﹤0.01%	301
2019 Q4	$276K	Sell	931 -152	-14%	-$42.2K	﹤0.01%	339
2019 Q3	$252K	Buy	1,083 +10	+0.9%	+$2.33K	﹤0.01%	315
2019 Q2	$251K	Buy	1,073 +63	+6%	+$14.5K	﹤0.01%	290
2019 Q1	$239K	Buy	+1,010	New	+$318K	﹤0.01%	295

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Personal Capital Advisors's BIIB Position: Q4 2021 in Review

Personal Capital Advisors sold out of Biogen (BIIB) in Q4 2021, closing a stake of 739 shares — an estimated $209K sold.

Personal Capital Advisors first reported a position in BIIB in Q1 2019 and held it in 10 quarters. The position peaked at $276K in Q4 2019. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Personal Capital Advisors reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
Personal Capital Advisors sold 739 Biogen shares in Q4 2021, an estimated $209K.
Personal Capital Advisors first reported a position in Biogen in Q1 2019 and held it in 10 quarters.
Personal Capital Advisors's Biogen position peaked at $276K in Q4 2019.
1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Personal Capital Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.